|
Model Number CB11R31R |
Device Problem
Obstruction of Flow (2423)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/22/2024 |
Event Type
malfunction
|
Event Description
|
Medtronic received information that during use of a custom tubing pack, it was reported that when trying to transfer blood out of the collection bag to the patient, flow through the left hand side port (as you are looking at the graduations on the bag) was slow and appeared impeded.The right hand port was used without any issues of flow.A second case occurred today with the same incident according to the customer.This is the report of the first case today which had the exact same issue.There were no issues to the patient as they were able to use the right hand side port. there was no adverse patient effect associated with this event.Medtronic received additional information that the blockage was in the left hand side port if looking at the graduations on the bag.The patient was on cardiopulmonary bypass for 1.45 hours when the blockage occurred.Crystalloid solution was used during prime.The patient had not previously been on heparin or other anti- coagulant therapy.Anti-coagulation was assessed using the act plus instrument.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|